BMJ Best Practice

参考文献

关键文献

American Urological Association. Urotrauma: AUA guideline (2014; amended 2017). 2018 [internet publication].

American Urological Association. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. 2012 [internet publication].

Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy - part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001 Apr;57(4):604-10.

参考文章

1.  Nielsen M, Qaseem A. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016 Apr 5;164(7):488-97.

2.  Kaag MG, Raman JD. Clinical guidelines: Clearing murky water - a guideline-based approach to haematuria. Nat Rev Urol. 2016 Apr 13;13(5):243-4.

3.  Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013 Jan 9;88(2):129-38.

4.  Edwards TJ, Dickinson AJ, Natale S, et al. A prospective analysis of the diagnostic yield resulting from 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006 Feb;97(2):301-5.

5.  Buntinx F, Wauters H. The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis. Fam Pract. 1997 Feb;14(1):63-8.

6.  Hicks D, Li CY. Management of macroscopic haematuria in the emergency department. Emerg Med J. 2007 Jun;24(6):385-90.

7.  National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Jul 2017 [internet publication].

8.  Jefferies ER, Brewster SF, BAUS Section on Oncology. Urological recommendations from the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: Suspected cancer: recognition and referral. BJU Int. 2015 Nov 14;117(6):857-60.

9.  Tanagho EA, McAninch JW. Smith's general urology, 16th ed. New York, NY: McGraw-Hill; 2003.

10.  Lee LW, Davis E Jr. Gross urinary hemorrhage: a symptom not a disease. JAMA. 1953 Oct 31;153(9):782-4.

11.  Chapple CR. Urethral injury. BJU Int. 2000 Aug;86(3):318-26.

12.  Macey MR, Raynor MC. Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: a review. Semin Intervent Radiol. 2016 Sep;33(3):217-23.

13.  Foley SJ, Soloman LZ, Wedderburn AW, et al. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Urol. 2000 Feb;163(2):496-8.

14.  Nyman MA, Schwenk NM, Silverstein MD. Management of urinary retention: rapid versus gradual decompression and risk of complications. Mayo Clin Proc. 1997 Oct;72(10):951-6.

15.  Subiela JD, Balla A, Bollo J, et al. Endovascular management of ureteroarterial fistula: single institution experience and systematic literature review. Vasc Endovascular Surg. 2018 Feb 26;52(4):275-86.

16.  De Costa C, McLaughlin K, Noseworthy TW. Criteria for referring patients with renal disease for nephrology consultation: a review of the literature. J Nephrol. 2010 Jul-Aug;23(4):399-407.

17.  Van Savage JG, Fried FA. Anticoagulant associated hematuria: a prospective study. J Urol. 1995 May;153(5):1594-6.

18.  Mariani AJ. The evaluation of adult hematuria: a clinical update. In: AUA update series 1998; volume XVII, lesson 24. Houston, TX: AUA Office of Education; 1998:185-92.

19.  Leapman MS, Hall SJ, Stone NN, et al. Haematuria after prostate brachytherapy. BJU Int. 2013 Jan 29;111(8):E319-24.

20.  Barnes H, Holland AE, Westall GP, et al. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database Syst Rev. 2018 Jan 3;(1):CD010908.

21.  American Urological Association. Urotrauma: AUA guideline (2014; amended 2017). 2018 [internet publication].

22.  Moharamzadeh P, Ojaghihaghighi S, Amjadi M, et al. Effect of tranexamic acid on gross hematuria: a pilot randomized clinical trial study. Am J Emerg Med. 2017 Sep 9;35(12):1922-5.

23.  American Urological Association. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. 2012 [internet publication].

24.  Yeoh M, Lai NK, Anderson D, et al. Macroscopic haematuria - a urological approach. Aust Fam Physician. 2013 Mar;42(3):123-6.

25.  Moloney F, Murphy KP, Twomey M, et al. Haematuria: an imaging guide. Adv Urol. 2014;2014:414125.

26.  Lucca I, Klatte T, Fajkovic H, et al. Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol. 2015 Oct;12(10):585-92.

27.  Sing RI, Singal RK. What is significant hematuria for the primary care physician? Can J Urol. 2012 Oct;19(suppl 1):36-41.

28.  Bagnall P. Haematuria: classification, causes and investigations. Br J Nurs. 2014 Nov 6-26;23(20):1074-8.

29.  Hicks D, Li CY. Management of macroscopic haematuria in the emergency department. Postgrad Med J. 2008 Oct;84(996):539-44.

30.  Tasian GE, Jemielita T, Goldfarb DS, et al. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 2018 May 10;29(6):1731-40.

31.  Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy - part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001 Apr;57(4):604-10.

32.  National Institute for Health and Care Excellence. Renal and ureteric stones: assessment and management. Jan 2019 [internet publication].

33.  Chlapoutakis K, Theocharopoulos N, Yarmenitis S, et al. Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol. 2010 Feb;73(2):334-8.

34.  Wang LJ, Wong YC, Huang CC, et al. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol. 2010 Jan;183(1):48-55.

35.  Sourtzis S, Thibeau JF, Damry N, et al. Radiologic investigation of renal colic: unenhanced helical CT compared with excretory urography. AJR Am J Roentgenol. 1999 Jun;172(6):1491-4.

36.  Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, et al; CT Urography Working Group of the European Society of Urogenital Radiology (ESUR). CT urography: definition, indications and techniques: a guideline for clinical practice. Eur Radiol. 2008 Jan;18(1):4-17.

37.  Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006 Apr;(100):S11-5.

38.  American College of Radiology. ACR appropriateness criteria: hematuria - child. 2018 [internet publication].

39.  Paner GP, Zehnder P, Amin AM, et al. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol. 2011 Jan;18(1):79-89.

40.  Silverman SG, Leyendecker JR, Amis ES Jr. What is the current role of CT urography and MR urography in the evaluation of the urinary tract? Radiology. 2009 Feb;250(2):309-23.

41.  Willis SR, Ahmed HU, Moore CM, et al. Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis. BMJ Open. 2014 Jun 15;4(6):e004895.

42.  Ngo B, Papa N, Perera M, et al. Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines. BJU Int. 2017 May;119 Suppl 5:53-4.

43.  American College of Radiology. ACR appropriateness criteria: hematuria. 2014 [internet publication].

44.  Pappas PG. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am. 1991 Mar;75(2):313-25.

45.  Maier U, Simak R, Neuhold N. The clinical value of urinary cytology: 12 years of experience with 615 patients. J Clin Pathol. 1995 Apr;48(4):314-7.

46.  National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management (update). Draft for consultation. Dec 2018 [internet publication].

47.  Harada T, Abe T, Kato F, et al. Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma. BMC Urol. 2015 Sep 4;15:91.

48.  Morey AF, McAninch JW, Tiller BK, et al. Single shot intraoperative excretory urography for the immediate evaluation of renal trauma. J Urol. 1999 Apr;161(4):1088-92.

49.  American College of Radiology. ACR appropriateness criteria: suspected lower urinary tract trauma. 2013 [internet publication].

50.  Colville DJ, Savige J. Alport syndrome. A review of the ocular manifestations. Ophthalmic Genet. 1997 Dec;18(4):161-73.

51.  Warshauer DM, McCarthy SM, Street L, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988 Nov;169(2):363-5.

52.  Dong XQ, Shen Y, Xu LW, et al. Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma. Chin Med J (Engl). 2009 May 20;122(10):1179-83.

53.  Heidenreich A, Ravery V; European Society of Oncological Urology. Preoperative imaging in renal cell cancer. World J Urol. 2004 Nov;22(5):307-15.

54.  Silverman SG, Israel GM, Herts BR, et al. Management of the incidental renal mass. Radiology. 2008 Oct;249(1):16-31.

55.  Swartz MA, Porter MP, Lin DW, et al. Incidence of primary urethral carcinoma in the United States. Urology. 2006 Dec 4;68(6):1164-8.

56.  Grellety T, Houédé N, Hoepffner JL, et al. Hemorrhagic cystitis in patients treated with cabazitaxel: a radiation recall syndrome? Ann Oncol. 2014 Apr 1;25(6):1248-9.

使用此内容应接受我们的免责声明